Kraig Biocraft Laboratories (KBLB) Total Current Liabilities (2010 - 2025)

Kraig Biocraft Laboratories (KBLB) has 16 years of Total Current Liabilities data on file, last reported at $10.4 million in Q4 2025.

• For the quarter ending Q4 2025, Total Current Liabilities rose 8.64% year-over-year to $10.4 million; the trailing twelve-month figure through Dec 2025 stood at $10.4 million (up 8.64% YoY), and the FY2025 full-year result was $10.4 million, up 8.64% from the prior year.
• Total Current Liabilities grew to $10.4 million in Q4 2025, from $10.2 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $10.4 million in Q4 2025 to a low of $7.8 million in Q1 2021.
• A 5-year average of $9.0 million and a median of $8.9 million in 2023 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities surged 35.98% in 2021 and fell 8.58% in 2023, its largest moves.
• Tracing KBLB's Total Current Liabilities over 5 years: stood at $8.2 million in 2021, then decreased by 1.11% to $8.1 million in 2022, then increased by 10.08% to $8.9 million in 2023, then climbed by 8.2% to $9.6 million in 2024, then increased by 8.64% to $10.4 million in 2025.
• Business Quant data shows KBLB's Total Current Liabilities at $10.4 million in Q4 2025, $10.2 million in Q3 2025, and $10.0 million in Q2 2025.